81 / 140
79
Notes
to financial statements
(
`
cr)
NOTE 18 SHORT-TERM LOANS AND ADVANCES
As at
March 31, 2013
As at
March 31, 2012
(a) To related parties, Unsecured, considered good
3.76
7.69
(b) Others, Unsecured, considered good:
(i) Advances recoverable in cash or kind
75.39
58.61
(ii) Balances with statutory authorities
23.48
19.69
(iii) Sundry deposits
0.83
0.75
(iv) Mark-to-Market gains on derivatives
2.54
-
(v) Others
-
0.20
106.00
86.94
(
`
cr)
NOTE 19 OTHER CURRENT ASSETS
As at
March 31, 2013
As at
March 31, 2012
(a) Export incentive receivable
16.91
17.18
(b) Sundry receivable
Doubtful
0.19
0.19
Less: Provision for doubtful receivable
0.19
0.19
16.91
17.18
(
`
cr)
NOTE 20 REVENUE FROM OPERATIONS
2012-13
2011-12
Sale of products
2,126.80
1,869.40
Sale of services
1.39
3.22
Other operating revenue:
Export incentives
26.08
23.35
Scrap sales
6.38
5.30
Processing charges
3.76
0.14
2,164.41
1,901.41
Less: Excise Duty
162.93
123.73
2,001.48
1,777.68
(
`
cr)
DETAILS OF REVENUE
2012-13
2011-12
Sale of products
Life Science Chemicals
762.11
642.86
Performance & Other Chemicals
1,364.69
1,226.54
Gross revenue
2,126.80
1,869.40
Sale of services
1.39
3.22
Other operating revenues
36.22
28.79
2,164.41
1,901.41
Less: Excise duty
162.93
123.73
2,001.48
1,777.68
(
`
cr)
NOTE 21 OTHER INCOME
2012-13
2011-12
Dividend on long-term investments
3.41
1.59
Interest from inter company deposits
0.76
1.12
Interest from others
0.15
1.23
Provisions no longer required
4.58
3.69
6XUSOXV RQ VDOH RI À[HG DVVHWV
0.86
0.28
Technical know-how
3.75
2.88
Miscellaneous income
5.00
3.59
18.51
14.38